The amount of fiber needed to manage constipation versus what might trigger diarrhea can differ
Conversely, if you're unable to take your GLP-1 medication due to illness, blood glucose levels may rise
The Food and Drug Administration (FDA) on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and Wegovy, is no longer in short supply
It happens when you think your current injection is not working for you
Since semaglutide is a long-acting medication, it remains in your body for a significantly longer period than most medications
MetaVia Announces Positive Top-Line Data From the 4-Week Phase 1 MAD Trial of DA-1726, a Novel 3:1 Ratio GLP-1 Glucagon Dual Receptor Agonist to Treat Obesity, Showing Compelling Weight Loss and Safety Effects With Potential Best-In-Class Glucose Control (GLP-1R), Waist Reduction (GCGR), and Tolerability News provided by MetaVia Inc